Lipophilic drugs

Lipophilic drugs are a broad category of pharmacological agents characterized by their high solubility in lipids and low solubility in water, typically defined by a positive partition coefficient (LogP). This physicochemical property allows them to readily cross biological membranes, including the blood-brain barrier, via passive diffusion (StatPearls, 2023). While lipophilicity is often a desirable trait for drugs targeting the central nervous system or intracellular components, it significantly influences the drug's pharmacokinetic profile, often resulting in a high volume of distribution and a heavy reliance on hepatic metabolism for clearance (NIH, 2021). Consequently, these drugs may exhibit prolonged half-lives and a tendency to accumulate in adipose tissue, which can lead to specific therapeutic challenges such as delayed recovery or toxicity (PubMed, 2022). Understanding the lipophilicity of a compound is a fundamental aspect of drug discovery and development, as it is a primary determinant of a drug's absorption, distribution, metabolism, and excretion (ADME) characteristics (Journal of Pharmaceutical Sciences, 2020).

Other names

Hydrophobic drugsFat-soluble drugsLipid-soluble drugsNon-polar drugs

Lipophilic drugs do not share a single mechanism of action; rather, their lipophilicity allows them to cross cell membranes via passive diffusion to reach various intracellular or central nervous system targets (StatPearls, 2023). Once inside the cell or across the blood-brain barrier, they bind to specific receptors, enzymes, or ion channels to exert their therapeutic effects (NIH, 2021).